Clarus Therapeutics, Inc. Seeks Injunction Against the Marketing of Lipocine, Inc.'s Oral Product for Testosterone Replacement Therapy (LPCN 1021)
November 02, 2015 10:22 ET
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc. today filed a lawsuit against Lipocine, Inc. for infringing a Clarus patent, namely U.S. Patent 8,828,428 ("the '428...
Clarus Therapeutics Reports FDA Advisory Committees Vote on REXTORO(TM) for Low Testosterone in Men
September 18, 2014 14:38 ET
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc. announced today that the U.S. Food and Drug Administration's (FDA) Bone, Reproductive and Urologic Drugs Advisory...
Clarus Therapeutics Expands Board of Directors With Appointment of Two Pharmaceutical Industry Veterans
July 21, 2014 08:30 ET
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., July 21, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO®, an...
Clarus Therapeutics Presents Phase 3 Data for REXTORO(R) for Men With Hypogonadism
June 22, 2014 14:00 ET
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., June 22, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO (...
Clarus Therapeutics Secures $31.5 Million in Financing
June 12, 2014 08:30 ET
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., June 12, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral...
Clarus Therapeutics to Present Phase 3 Data for REXTORO(R) at ICE/ENDO 2014
May 28, 2014 08:30 ET
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., May 28, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral...
Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer
May 21, 2014 08:30 ET
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., May 21, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral...
Clarus Therapeutics Appoints John Gargiulo Chief Operating Officer
March 17, 2014 08:30 ET
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., March 17, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral...